Cegedim (ALCGM) AI Stock Analysis

• Market Cap: €145.37M
• Dividend Yield: N/A
• Average Volume (3M): 7.31K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.31
• Revenue Growth: 3.79%
• EPS Growth: -797.10%
• Country: FR
• Employees: 6,700
• Sector: Technology
• Sector Strength: 88
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.10
• Shares Outstanding: 14,097,155
• 10 Day Avg. Volume: 6,488
• 30 Day Avg. Volume: 7,312
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €12.50
• Price Target Upside: 17.92% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 54 Neutral
• Price Target: €11.00 ▲(3.77% Upside)

Cegedim's overall stock score is primarily impacted by its financial performance challenges, including negative net income and fluctuating cash flows. Technical indicators suggest a bearish trend, and valuation metrics highlight profitability concerns. The absence of earnings call insights and corporate events leaves these factors unaddressed.

Cegedim Business Overview & Revenue Model

Company Description

Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide. It operates in two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This division also provides solutions for hosting, HR and payroll management outsourcing, and electronic data exchange services. The Healthcare Professionals division offers management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SA.

How the Company Makes Money

Cegedim generates revenue through several key streams: subscription fees for its software solutions, licensing agreements for its proprietary data and analytics services, and consulting services aimed at optimizing healthcare practices. The company also benefits from partnerships with pharmaceutical companies and healthcare providers, which often involve joint ventures or collaborations that enhance product offerings and increase market reach. Additionally, Cegedim capitalizes on its extensive databases and analytics capabilities, providing valuable insights and reporting services that are essential for compliant and efficient healthcare operations.

Cegedim Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Cegedim Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.60
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALCGM, the sentiment is Positive. The current price of 10.6 is above the 20-day moving average (MA) of 10.26, above the 50-day MA of 10.49, and below the 200-day MA of 11.60, indicating a neutral trend. The MACD of -0.08 indicates Negative momentum. The RSI at 60.97 is Neutral, neither overbought nor oversold. The STOCH value of 74.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALCGM.

Cegedim Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EQS	67 Neutral	668.41M	18.49	15.64%	2.81%	4.47%	-14.37%
ALCGM	54 Neutral	€145.37M	―	-5.21%	―	3.79%	-797.10%
AL2SI	52 Neutral	203.57M	―	―	―	―	―
ALKEY	52 Neutral	122.28M	222.54	0.58%	―	-4.25%	-84.17%
CLA	45 Neutral	95.59M	-28.15	―	―	-0.95%	49.19%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%